Impact of COVID-19 on Goodwill Impairment � Perspectives from U.S. GAAP and IFRS

Duration: 1 hour

Download Webcast Slide

Topics

• Background on how the COVID-19 economic environment is impacting goodwill impairment testing
• Identifying triggering events and deciding whether an impairment test is appropriate
• Adjusting cash flow projections 
• Selecting discount rate assumptions
• Addressing stock market price fluctuations and reconciling value conclusions
• Highlighting similarities and differences between U.S. GAAP and IFRS

Speakers

• Greg Franceschi, Managing Director, Valuation Services and Global Head of the Financial Reporting Practice and Office of Professional Practice
• Carla Nunes, Managing Director, Valuation Digital Solutions and Office of Professional Practice
• Javier Zoido, Managing Director, Valuation Services
• Andrew Probert, Managing Director, Transaction Advisory Services